UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000025237
Receipt No. R000028912
Scientific Title Motion and electromyographical analysis of stroke rehabilitation
Date of disclosure of the study information 2016/12/14
Last modified on 2018/02/24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Motion and electromyographical analysis of stroke rehabilitation
Acronym Motion and EMG analysis of stroke rehabilitation
Scientific Title Motion and electromyographical analysis of stroke rehabilitation
Scientific Title:Acronym Motion and EMG analysis of stroke rehabilitation
Region
Japan

Condition
Condition Stroke
Classification by specialty
Rehabilitation medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Objective evaluation of the effect of stroke rehabilitation
Basic objectives2 Others
Basic objectives -Others evaluation
Trial characteristics_1 Confirmatory
Trial characteristics_2 Explanatory
Developmental phase Not applicable

Assessment
Primary outcomes Kinematic parameter and EMG pattern associated with motion
Key secondary outcomes Fugl-Meyer Assessment

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Maneuver
Interventions/Control_1 Evaluation of performances (standing up, walking or movement of the paralytic upper extremity) immediately before and after ten-minute rehabilitation by 3D motion analysis and electromyography.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
90 years-old >
Gender Male and Female
Key inclusion criteria Patients having first-ever stroke.
Patients whose general medical condition is stable (by reference to the criteria by Anderson-Doi)
Patients who receive physical or occupational therapy including the exercise equivalent to or more advanced than the movement planned in the study.
Patients who can sit by themselves.
Key exclusion criteria Patients whose general condition was poor to perform the task.
Patients having difficulties in understanding the study design, providing consent to, or participating in the study due to hearing or visual impairment, cognitive impairment, aphasia or dementia.
Patients having past history of severe neurological or psychiatric diseases such as brain tumor, epilepsy, Parkinson's disease.
Patients having contraindication for MRI.
Target sample size 90

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Noriaki Hattori
Organization Morinomiya Hospital
Division name Neurorehabilitation Research Institute
Zip code
Address 2-1-88, Morinomiya, Joto-ku, Osaka-shi, Osaka, Japan
TEL 06-6969-0111
Email hattori@omichikai.or.jp

Public contact
Name of contact person
1st name
Middle name
Last name Yoko Okuda
Organization Morinomiya Hospital
Division name Neurorehabilitation Research Institute
Zip code
Address 2-1-88, Morinomiya, Joto-ku, Osaka-shi, Osaka, Japan
TEL 06-6969-0111
Homepage URL
Email okuda@omichikai.or.jp

Sponsor
Institute Neurorehabilitation Research Institute, Morinomiya Hospital
Institute
Department

Funding Source
Organization Neurorehabilitation Research Institute, Morinomiya Hospital
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor RIKEN Brain Science Institute
National Institute of Neuroscience, National Center for Neurology and Psychiatry
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2016 Year 12 Month 14 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2016 Year 05 Month 12 Day
Date of IRB
Anticipated trial start date
2016 Year 07 Month 06 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information

Management information
Registered date
2016 Year 12 Month 12 Day
Last modified on
2018 Year 02 Month 24 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028912

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.